Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Rituximab
MabThera
Not routinely available
SMC (SMC2193)
13/05/2019
Indication
Treatment of patients with moderate to severe pemphigus vulgaris.
Therapeutic Area
Skin
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
100mg Concentrate for Solution for Infusion
Comments
None
Link to Advice
Advice Published
13/05/2019
SMC Submission Type
Non submission
SMC Status
Not recommended